Abstract
Hypertension is one of the most common noncommunicable chronic diseases and is an important risk factor for vascular complications. The prevalence of hypertension is very high worldwide, and it is still increasing in low- and middle-income countries. Although some improvements were reported in high-income countries in recent years, there is still much to do to overcome hypertension and its complications. Identically, hypertension is a severe public health issue in Turkey. Approximately one third of the adult population has got hypertension but almost half is unaware of the disease. Children and youths are also affected by the burden of hypertension. Increased body mass index and obesity frequently accompany hypertension in children and adolescents. Major contributors to the disease burden appears to be consumption of high amounts of dietary sodium, lack of appropriate physical activity, increasing weight and obesity. In the last decades, an improvement at disease awareness has been achieved but blood-pressure control rates are still low in Turkey. Traditional and natural products, including lemon juice and garlic, are very popular among patients with concerns regarding medications’ side effects. Patients’ adherence to therapy differs between regions and increases in parallel with high education level. Decreasing daily salt intake has been shown to reduce the prevalence of hypertension substantially and to prevent cardiovascular and cerebrovascular deaths in a cost effective manner in projection studies. Finally, improving education of patients, which has positive effects on disease awareness, treatment adherence, and blood-pressure control rates, should be considered.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
137,91 €
only 11,49 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019 Jun 22; 393(10190):e44] [published correction appears in Lancet. 2018 Nov 17; 392(10160):2170]. Lancet. 2018;392:1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American heart association Task Force on clinical practice guidelines. Circulation. 2019;140:e596–646.
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141:e139–596.
Wang G, Fang J, Ayala C. Hypertension-associated hospitalizations and costs in the United States, 1979–2006. Blood Press. 2014;23:126–33. https://doi.org/10.3109/08037051.2013.814751.
Weaver CG, Clement FM, Campbell NR, James MT, Klarenbach SW, Hemmelgarn BR, et al. Healthcare costs attributable to hypertension: Canadian Population-Based Cohort Study. Hypertension. 2015;66:502–8. https://doi.org/10.1161/HYPERTENSIONAHA.115.05702.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50. https://doi.org/10.1161/CIRCULATIONAHA.115.018912. PMID: 27502908; PMCID:PMC4979614.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13. https://doi.org/10.1016/s0140-6736(02)11911-8.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 2020;395:795–808. https://doi.org/10.1016/S0140-6736(19)32008-2.
Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in. J Hypertens. 2005;23:1817–23.
Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1208–17. https://doi.org/10.1097/HJH.0000000000000901.
Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001;156:1–10.
Population by years, age group and sex, census of population—ABPRS. Turkish Statistical Institute report. 2020. http://www.turkstat.gov.tr/PreTablo.do?alt_id=1059.
Onat A, Can G, Yüksel H, Ademoğlu E, Erginel-Ünaltuna N, Kaya A, et al. TEKHARF 2017 Tıp Dünyasının Kronik Hastalıklara Yaklaşımına Öncülük. 2017. https://file.tkd.org.tr/PDFs/TEKHARF-2017.pdf.
The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years. World Health Stat Q. 1988;41:115–40.
NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51. https://doi.org/10.1016/S0140-6736(19)31145-6.
Alper Z, Ercan İ, Uncu Y. A meta-analysis and an evaluation of trends in obesity prevalence among children and adolescents in Turkey: 1990 through 2015. J Clin Res Pediatr Endocrinol. 2018;10:59–67. https://doi.org/10.4274/jcrpe.5043.
Duzova A, Yalçınkaya F, Baskin E, Bakkaloglu A, Soylemezoglu O. Prevalence of hypertension and decreased glomerular filtration rate in obese children: results of a population-based field study. Nephrol Dialysis Transplant. 2013;28 Suppl 4:iv166–71. https://doi.org/10.1093/ndt/gft317.
Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health. 2009;31:47–58.
Sariişik A, Oğuz A, Uzunlulu M. Control of hypertension in Turkey—is it improving? The Kocaeli 2 study. Turk Kardiyol Dern Ars. 2009;37 Suppl 6:13–6.
Doğan N, Toprak D, Demir S. Hypertension prevalence and risk factors among adult population in Afyonkarahisar region: a cross-sectional research. Anadolu Kardiyol Derg. 2012;12:47–52.
Sönmez HM, Başak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, et al. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey. J Hum Hypertens. 1999;13:399–404.
Abaci A, Oguz A, Kozan O, Toprak N, Senocak H, Deger N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hypertens. 2006;20:355–61. https://doi.org/10.1038/sj.jhh.1001995.
Seravalle G, Koylan N, Nalbantgil I, Caglar N, Quarti-Trevano F, Makel W, et al. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. High Blood Press Cardiovasc Prev. 2015;22:165–72. https://doi.org/10.1007/s40292-015-0091-6.
Altun B, Süleymanlar G, Utaş C, Arınsoy T, Ateş K, Ecder T, et al. Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT Study. Kidney Blood Press Res. 2012;36:36–46.
Ulusoy Ş, Özkan G, Arıcı M, Derici Ü, Akpolat T, Şengül Ş, et al. Which out-of-office measurement technique should be used for diagnosing hypertension in prehypertensives? J Hum Hypertens. 2020;34:586–92. https://doi.org/10.1038/s41371-019-0284-x.
Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü, Abacı A, et al. Türk Hipertansiyon Uzlaşı Raporu 2019 [2019 Turkish Hypertension Consensus Report]. Turk Kardiyol Dern Ars. 2019;47:535–46. https://doi.org/10.5543/tkda.2019.62565.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8) [published online December 18, 2013]. JAMA. https://doi.org/10.1001/jama.2013.284427.
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021–104. https://doi.org/10.1093/eurheartj/ehy339.
He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis. 2010;52:363–82.
He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta- analysis of randomised trials. BMJ. 2013;346:f1325.
Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326.
He FJ, MacGregor GA. Role of salt intake in prevention of cardiovascular disease: controversies and challenges. Nat Rev Cardiol. 2018;15:371–7. https://doi.org/10.1038/s41569-018-0004-1.
Erdem Y, Arici M, Altun B, Turgan C, Sindel S, Erbay B, et al. The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press. 2010;19:313–8. https://doi.org/10.3109/08037051003802541.
Erdem Y, Akpolat T, Derici Ü, Şengül Ş, Ertürk Ş, Ulusoy Ş, et al. Dietary sources of high sodium intake in Turkey: SALTURK II. Nutrients. 2017;9:933. https://doi.org/10.3390/nu9090933.
National Household Health Survey—prevalence of noncommunicable disease risk factors in Turkey 2017 (2018). https://www.euro.who.int/__data/assets/pdf_file/0008/383984/turkey-risk-factors-eng.pdf.
Oğuz S, Yanmış S, Yılmaz B, Atman R. Hipertansiyon Hastalarının İlaç ve Diyet Tedavisine Uyum Düzeyleri. Turk. J Cardiovasc Nurs. 2019;10:1–7. https://doi.org/10.5543/khd.2019.63644.
Uzun S, Kara B, Yokuşoğlu M, Arslan F, Yilmaz MB, Karaeren H. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations. Anadolu Kardiyol Derg. 2009;9:102–9.
Hacihasanoğlu R, Gözüm S. The effect of patient education and home monitoring on medication compliance, hypertension management, healthy lifestyle behaviours and BMI in a primary health care setting. J Clin Nurs. 2011;20:692–705. https://doi.org/10.1111/j.1365-2702.2010.03534.x.
Polat M, Yıkılkan H, Aypak C, Görpelioğlu S. The relationship between BMI and blood pressure in children aged 7–12 years in Ankara, Turkey. Public Health Nutr. 2014;17:2419–24. https://doi.org/10.1017/S1368980014000846.
Akış N, Pala K, Meriç-Utku A, Bingöl S, Sarandöl E, Aytekin H. Hypertension in children (12–14 years)—a case–control study in Bursa, Turkey. Turk J Pediatr. 2009;51:437–43.
Nur N, Çetinkaya S, Yilmaz A, Ayvaz A, Bulut MO, Sümer H. Prevalence of hypertension among high school students in a middle Anatolian Province of Turkey. J Health Popul Nutr. 2008;26:88–94.
Dinç G, Saatli G, Baydur H, Ozcan C. Hypertension and overweight among Turkish adolescents in a city in Aegean region of Turkey: a strong relationship in a population with a relatively low prevalence of overweight. Anadolu Kardiyol Derg. 2009;9:450–6.
Çam HH, Ustuner Top F. Prevalence of hypertension and its association with body mass index and waist circumference among adolescents in Turkey: a cross-sectional study. J Pediatr Nurs. 2020. https://doi.org/10.1016/j.pedn.2020.09.017.
Adibelli Z, Dilek M, Akpolat T. Lemon juice as an alternative therapy in hypertension in Turkey. Int J Cardiol. 2009;135:e58–9. https://doi.org/10.1016/j.ijcard.2008.03.085.
Gücük İpek E, Güray Y, Demirkan B, Güray U, Kafes H, Başyiğit F. The prevalence of alternative herbal medicine and nutritional complementary product intake in patients admitted to out-patient cardiology departments. Turk Kardiyol Dern Ars. 2013;41:218–24. https://doi.org/10.5543/tkda.2013.15146.
Public Health Agency of Turkey. Chronic diseases and risk factors survey in Turkey. Ankara: Public Health Agency of Turkey; 2013. https://sbu.saglik.gov.tr/ekutuphane/kitaplar/khrfai.pdf. Accessed 25 Apr 2018.
Yurekli AA, Bilir N, Husain MJ. Projecting burden of hypertension and its management in Turkey, 2015–2030. PLoS ONE. 2019;14:e0221556. https://doi.org/10.1371/journal.pone.0221556.
Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr. 2007;61:548–53. https://doi.org/10.1038/sj.ejcn.1602554.
Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28:169–80.
Author information
Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pamukcu, B. Profile of hypertension in Turkey: from prevalence to patient awareness and compliance with therapy, and a focus on reasons of increase in hypertension among youths. J Hum Hypertens (2021). https://doi.org/10.1038/s41371-020-00480-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41371-020-00480-6